SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001193125-16-646347
Filing Date
2016-07-12
Accepted
2016-07-12 16:00:56
Documents
5
Period of Report
2016-07-12
Items
Item 1.02: Termination of a Material Definitive Agreement
Item 2.01: Completion of Acquisition or Disposition of Assets
Item 3.01: Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing
Item 3.03: Material Modifications to Rights of Security Holders
Item 5.01: Changes in Control of Registrant
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
Item 5.03: Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K d225190d8k.htm 8-K 28626
2 EX-3.1 d225190dex31.htm EX-3.1 5756
3 EX-3.2 d225190dex32.htm EX-3.2 58999
4 EX-99.1 d225190dex991.htm EX-99.1 6554
5 GRAPHIC g225190g94q28.jpg GRAPHIC 11323
  Complete submission text file 0001193125-16-646347.txt   117357
Mailing Address 303B COLLEGE ROAD EAST PRINCETON NJ 08540
Business Address 303B COLLEGE ROAD EAST PRINCETON NJ 08540 (609) 243-0123
Celator Pharmaceuticals Inc (Filer) CIK: 0001327467 (see all company filings)

IRS No.: 202680869 | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-36179 | Film No.: 161764027
SIC: 2834 Pharmaceutical Preparations